1.ARCO Consensus on the Pathogenesis of Non-traumatic Osteonecrosis of the Femoral Head
Quanjun CUI ; Woo-Lam JO ; Kyung-Hoi KOO ; Edward Y. CHENG ; Wolf DRESCHER ; Stuart B. GOODMAN ; Yong-Chan HA ; Phillippe HERNIGOU ; Lynne C. JONES ; Shin-Yoon KIM ; Kyu Sang LEE ; Mel S. LEE ; Yun Jong LEE ; Michael A. MONT ; Nobuhiko SUGANO ; John TALIAFERRO ; Takuaki YAMAMOTO ; Dewei ZHAO
Journal of Korean Medical Science 2021;36(10):e65-
Osteonecrosis of the femoral head (ONFH) is a devastating disease frequently leading to femoral head collapse and hip arthritis. Specifically, non-traumatic ONFH primarily affects young and middle-aged adults. Although compromised local circulation of the femoral head seems to be pathognomonic for the disease, the pathogenesis is perplexing and continues to be an area of scrutiny and research. Comprehension of the pathogenesis is of crucial importance for developing and guiding treatments for the disease. Therefore, we provide an up-to-date consensus on the pathogenesis of non-traumatic ONFH.
2.ARCO Consensus on the Pathogenesis of Non-traumatic Osteonecrosis of the Femoral Head
Quanjun CUI ; Woo-Lam JO ; Kyung-Hoi KOO ; Edward Y. CHENG ; Wolf DRESCHER ; Stuart B. GOODMAN ; Yong-Chan HA ; Phillippe HERNIGOU ; Lynne C. JONES ; Shin-Yoon KIM ; Kyu Sang LEE ; Mel S. LEE ; Yun Jong LEE ; Michael A. MONT ; Nobuhiko SUGANO ; John TALIAFERRO ; Takuaki YAMAMOTO ; Dewei ZHAO
Journal of Korean Medical Science 2021;36(10):e65-
Osteonecrosis of the femoral head (ONFH) is a devastating disease frequently leading to femoral head collapse and hip arthritis. Specifically, non-traumatic ONFH primarily affects young and middle-aged adults. Although compromised local circulation of the femoral head seems to be pathognomonic for the disease, the pathogenesis is perplexing and continues to be an area of scrutiny and research. Comprehension of the pathogenesis is of crucial importance for developing and guiding treatments for the disease. Therefore, we provide an up-to-date consensus on the pathogenesis of non-traumatic ONFH.
3.Osteonecrosis of the Femoral Head: an Updated Review of ARCO on Pathogenesis, Staging and Treatment
Jeremy T. HINES ; Woo-Lam JO ; Quanjun CUI ; Michael A. MONT ; Kyung-Hoi KOO ; Edward Y. CHENG ; Stuart B. GOODMAN ; Yong-Chan HA ; Phillippe HERNIGOU ; Lynne C. JONES ; Shin-Yoon KIM ; Takashi SAKAI ; Nobuhiko SUGANO ; Takuaki YAMAMOTO ; Mel S. LEE ; Dewei ZHAO ; Wolf DRESCHER ; Tae-Young KIM ; Young-Kyun LEE ; Byung-Ho YOON ; Seung-Hoon BAEK ; Wataru ANDO ; Hong-Seok KIM ; Jung-Wee PARK
Journal of Korean Medical Science 2021;36(24):e177-
Non-traumatic osteonecrosis of the femoral head (ONFH) usually affects adults younger than 50 years and frequently leads to femoral head collapse and subsequent arthritis of the hip.It is becoming more prevalent along with increasing use of corticosteroids for the adjuvant therapy of leukemia and other myelogenous diseases as well as management of organ transplantation. This review updated knowledge on the pathogenesis, classification criteria, staging system, and treatment of ONFH.
4.Osteonecrosis of the Femoral Head: an Updated Review of ARCO on Pathogenesis, Staging and Treatment
Jeremy T. HINES ; Woo-Lam JO ; Quanjun CUI ; Michael A. MONT ; Kyung-Hoi KOO ; Edward Y. CHENG ; Stuart B. GOODMAN ; Yong-Chan HA ; Phillippe HERNIGOU ; Lynne C. JONES ; Shin-Yoon KIM ; Takashi SAKAI ; Nobuhiko SUGANO ; Takuaki YAMAMOTO ; Mel S. LEE ; Dewei ZHAO ; Wolf DRESCHER ; Tae-Young KIM ; Young-Kyun LEE ; Byung-Ho YOON ; Seung-Hoon BAEK ; Wataru ANDO ; Hong-Seok KIM ; Jung-Wee PARK
Journal of Korean Medical Science 2021;36(24):e177-
Non-traumatic osteonecrosis of the femoral head (ONFH) usually affects adults younger than 50 years and frequently leads to femoral head collapse and subsequent arthritis of the hip.It is becoming more prevalent along with increasing use of corticosteroids for the adjuvant therapy of leukemia and other myelogenous diseases as well as management of organ transplantation. This review updated knowledge on the pathogenesis, classification criteria, staging system, and treatment of ONFH.